

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.84966127 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.47825693 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.47825693 |
| 4 | lysine metabolic process (GO:0006553) | 4.22797067 |
| 5 | lysine catabolic process (GO:0006554) | 4.22797067 |
| 6 | carnitine shuttle (GO:0006853) | 4.17209928 |
| 7 | mannose metabolic process (GO:0006013) | 4.11809693 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.07889394 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.07889394 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 3.97037170 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 3.89837392 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.87217304 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 3.75993406 |
| 14 | fatty acid beta-oxidation (GO:0006635) | 3.74931029 |
| 15 | short-chain fatty acid metabolic process (GO:0046459) | 3.61156634 |
| 16 | valine metabolic process (GO:0006573) | 3.55380123 |
| 17 | biotin metabolic process (GO:0006768) | 3.51854964 |
| 18 | fatty acid oxidation (GO:0019395) | 3.49225420 |
| 19 | kynurenine metabolic process (GO:0070189) | 3.47115995 |
| 20 | lipid oxidation (GO:0034440) | 3.42039735 |
| 21 | glyoxylate metabolic process (GO:0046487) | 3.39917789 |
| 22 | aspartate family amino acid catabolic process (GO:0009068) | 3.37798103 |
| 23 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35824579 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35673760 |
| 25 | histone H3-K36 demethylation (GO:0070544) | 3.34490993 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.34459114 |
| 27 | fatty acid catabolic process (GO:0009062) | 3.32615211 |
| 28 | acetyl-CoA metabolic process (GO:0006084) | 3.30923199 |
| 29 | carnitine transmembrane transport (GO:1902603) | 3.30653666 |
| 30 | regulation of ARF protein signal transduction (GO:0032012) | 3.30260862 |
| 31 | carnitine transport (GO:0015879) | 3.30078511 |
| 32 | amino-acid betaine transport (GO:0015838) | 3.30078511 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.29411046 |
| 34 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.21797579 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.20193334 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.20193334 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.20193334 |
| 38 | branched-chain amino acid metabolic process (GO:0009081) | 3.19682448 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 3.18081198 |
| 40 | tricarboxylic acid metabolic process (GO:0072350) | 3.15628528 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14948164 |
| 42 | branched-chain amino acid catabolic process (GO:0009083) | 3.12187076 |
| 43 | regulation of sequestering of triglyceride (GO:0010889) | 3.11078968 |
| 44 | positive regulation of Rap GTPase activity (GO:0032854) | 3.10129662 |
| 45 | bile acid biosynthetic process (GO:0006699) | 3.09252340 |
| 46 | positive regulation of histone deacetylation (GO:0031065) | 3.08981218 |
| 47 | tryptophan metabolic process (GO:0006568) | 3.08593396 |
| 48 | cysteine metabolic process (GO:0006534) | 3.08096543 |
| 49 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.05864945 |
| 50 | negative regulation of lipase activity (GO:0060192) | 3.05003521 |
| 51 | regulation of histone H3-K27 methylation (GO:0061085) | 3.04889384 |
| 52 | negative regulation of myotube differentiation (GO:0010832) | 3.02764040 |
| 53 | homocysteine metabolic process (GO:0050667) | 3.02703772 |
| 54 | monocarboxylic acid catabolic process (GO:0072329) | 3.02637800 |
| 55 | ethanol oxidation (GO:0006069) | 3.02155772 |
| 56 | positive regulation of fatty acid oxidation (GO:0046321) | 3.01690842 |
| 57 | drug transmembrane transport (GO:0006855) | 2.99332415 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 2.99006986 |
| 59 | phospholipid homeostasis (GO:0055091) | 2.98115885 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94816372 |
| 61 | creatine metabolic process (GO:0006600) | 2.92322017 |
| 62 | cellular hyperosmotic response (GO:0071474) | 2.91805658 |
| 63 | quaternary ammonium group transport (GO:0015697) | 2.90424547 |
| 64 | carnitine metabolic process (GO:0009437) | 2.89564104 |
| 65 | histone H3-K9 demethylation (GO:0033169) | 2.88234584 |
| 66 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.86732478 |
| 67 | response to mercury ion (GO:0046689) | 2.85262138 |
| 68 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.84337946 |
| 69 | regulation of fatty acid oxidation (GO:0046320) | 2.84126098 |
| 70 | histone lysine demethylation (GO:0070076) | 2.81386880 |
| 71 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81171498 |
| 72 | sulfur amino acid catabolic process (GO:0000098) | 2.80493412 |
| 73 | bile acid metabolic process (GO:0008206) | 2.80413587 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 2.80381980 |
| 75 | acylglycerol homeostasis (GO:0055090) | 2.77485813 |
| 76 | triglyceride homeostasis (GO:0070328) | 2.77485813 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 2.77248833 |
| 78 | focal adhesion assembly (GO:0048041) | 2.76930848 |
| 79 | cell-substrate adherens junction assembly (GO:0007045) | 2.76930848 |
| 80 | complement activation, alternative pathway (GO:0006957) | 2.76777444 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 2.76239670 |
| 82 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.75892404 |
| 83 | alpha-amino acid catabolic process (GO:1901606) | 2.74054219 |
| 84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.73581889 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71917293 |
| 86 | protein carboxylation (GO:0018214) | 2.71917293 |
| 87 | urea cycle (GO:0000050) | 2.71232876 |
| 88 | urea metabolic process (GO:0019627) | 2.71232876 |
| 89 | histone demethylation (GO:0016577) | 2.70971157 |
| 90 | adherens junction assembly (GO:0034333) | 2.70013719 |
| 91 | positive thymic T cell selection (GO:0045059) | 2.69104047 |
| 92 | macroautophagy (GO:0016236) | 2.68640482 |
| 93 | regulation of skeletal muscle contraction (GO:0014819) | 2.67621908 |
| 94 | embryonic process involved in female pregnancy (GO:0060136) | 2.67615231 |
| 95 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.63030573 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.62804466 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 2.60741248 |
| 98 | regulation of protein activation cascade (GO:2000257) | 2.59770000 |
| 99 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.59196914 |
| 100 | organic acid catabolic process (GO:0016054) | 2.59005655 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 2.59005655 |
| 102 | intracellular lipid transport (GO:0032365) | 2.59004213 |
| 103 | regulation of response to osmotic stress (GO:0047484) | 2.58682912 |
| 104 | negative regulation of necroptotic process (GO:0060546) | 2.58162760 |
| 105 | positive regulation of glycolytic process (GO:0045821) | 2.56823225 |
| 106 | regulation of Rap GTPase activity (GO:0032317) | 2.56392935 |
| 107 | definitive hemopoiesis (GO:0060216) | 2.56352093 |
| 108 | fatty acid homeostasis (GO:0055089) | 2.56063880 |
| 109 | ketone body metabolic process (GO:1902224) | 2.55043547 |
| 110 | NADH metabolic process (GO:0006734) | 2.54393196 |
| 111 | thymic T cell selection (GO:0045061) | 2.53335362 |
| 112 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52838875 |
| 113 | negative regulation of cell killing (GO:0031342) | 2.52838875 |
| 114 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52045113 |
| 115 | tyrosine metabolic process (GO:0006570) | 2.51819494 |
| 116 | glutamate metabolic process (GO:0006536) | 2.51181036 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 2.50670824 |
| 118 | myofibril assembly (GO:0030239) | 2.50011593 |
| 119 | regulation of fibrinolysis (GO:0051917) | 2.49823303 |
| 120 | regulation of cholesterol metabolic process (GO:0090181) | 2.49436365 |
| 121 | aromatic amino acid family metabolic process (GO:0009072) | 2.48364195 |
| 122 | regulation of RNA export from nucleus (GO:0046831) | 2.47401020 |
| 123 | response to laminar fluid shear stress (GO:0034616) | 2.47181587 |
| 124 | nitrogen cycle metabolic process (GO:0071941) | 2.47137169 |
| 125 | germinal center formation (GO:0002467) | 2.46382908 |
| 126 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.45827567 |
| 127 | regulation of ARF GTPase activity (GO:0032312) | 2.45651648 |
| 128 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.45237793 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.44925871 |
| 130 | cardiac myofibril assembly (GO:0055003) | 2.44440468 |
| 131 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.44136360 |
| 132 | regulation of complement activation (GO:0030449) | 2.43150051 |
| 133 | positive regulation of lipid catabolic process (GO:0050996) | 2.42309217 |
| 134 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40579351 |
| 135 | negative regulation of cell size (GO:0045792) | 2.40109589 |
| 136 | histone H4 deacetylation (GO:0070933) | 2.39218293 |
| 137 | glycogen catabolic process (GO:0005980) | 2.38698844 |
| 138 | skeletal muscle adaptation (GO:0043501) | 2.38419691 |
| 139 | drug catabolic process (GO:0042737) | 2.37684834 |
| 140 | muscle filament sliding (GO:0030049) | 2.36317759 |
| 141 | actin-myosin filament sliding (GO:0033275) | 2.36317759 |
| 142 | serine family amino acid catabolic process (GO:0009071) | 2.36113134 |
| 143 | COPI coating of Golgi vesicle (GO:0048205) | 2.35661075 |
| 144 | Golgi transport vesicle coating (GO:0048200) | 2.35661075 |
| 145 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.33965105 |
| 146 | 4-hydroxyproline metabolic process (GO:0019471) | 2.33883971 |
| 147 | plasma membrane repair (GO:0001778) | 2.33529025 |
| 148 | urate metabolic process (GO:0046415) | 2.32487329 |
| 149 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.31867607 |
| 150 | B cell receptor signaling pathway (GO:0050853) | 2.31649286 |
| 151 | cellular response to epinephrine stimulus (GO:0071872) | 2.31032472 |
| 152 | negative thymic T cell selection (GO:0045060) | 2.29696729 |
| 153 | positive regulation of myotube differentiation (GO:0010831) | 2.28940332 |
| 154 | protein demethylation (GO:0006482) | 2.28273416 |
| 155 | protein dealkylation (GO:0008214) | 2.28273416 |
| 156 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.27492266 |
| 157 | positive T cell selection (GO:0043368) | 2.24570248 |
| 158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.24294450 |
| 159 | oxaloacetate metabolic process (GO:0006107) | 2.24034491 |
| 160 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.22433620 |
| 161 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.22433620 |
| 162 | phospholipid efflux (GO:0033700) | 2.22340949 |
| 163 | cellular response to reactive nitrogen species (GO:1902170) | 2.22255653 |
| 164 | negative regulation of necrotic cell death (GO:0060547) | 2.22007417 |
| 165 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.21981854 |
| 166 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.21045556 |
| 167 | cell volume homeostasis (GO:0006884) | 2.20210024 |
| 168 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.19391660 |
| 169 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.18535490 |
| 170 | cardiac muscle contraction (GO:0060048) | 2.18422104 |
| 171 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.18028940 |
| 172 | Peyers patch development (GO:0048541) | 2.18028940 |
| 173 | T cell selection (GO:0045058) | 2.16507264 |
| 174 | protein-lipid complex assembly (GO:0065005) | 2.16258282 |
| 175 | gas transport (GO:0015669) | 2.15943617 |
| 176 | histone H3 deacetylation (GO:0070932) | 2.14660661 |
| 177 | negative regulation of fatty acid transport (GO:2000192) | 2.13496100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.31894313 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96029231 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.51841675 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.32505951 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.24866771 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.14114017 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.90806888 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.90806685 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.80377323 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.56369186 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.52936901 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51226026 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42745166 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.24814205 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.07103654 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00107694 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99007267 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92361797 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85397072 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81067727 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 1.78929497 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77443021 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76481435 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.71906361 |
| 25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.71906361 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66483655 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65955862 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65189964 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64868742 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59863200 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.59541267 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58160787 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57267744 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.54724455 |
| 35 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53456477 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52783901 |
| 37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.50799638 |
| 38 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.48745273 |
| 39 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47528969 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47521029 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47282259 |
| 42 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46346641 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46273330 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45655143 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42899368 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42677865 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42376504 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.42118247 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40402875 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.40333859 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39004632 |
| 52 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38473585 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37224163 |
| 54 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.36951513 |
| 55 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36920450 |
| 56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36486863 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32033635 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31885593 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31805282 |
| 60 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.30654511 |
| 61 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30580711 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26311014 |
| 63 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.24950221 |
| 64 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23716428 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22799666 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22077171 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21634207 |
| 68 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20246657 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19850380 |
| 70 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.19794914 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19209710 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17896730 |
| 73 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17822487 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17175221 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16639741 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15641345 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15474548 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13371733 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12144116 |
| 80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11419741 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10336545 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 1.09337502 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08510763 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07725403 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07672041 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07430754 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07115709 |
| 88 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.04130354 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02182581 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01480073 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98594606 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98257476 |
| 93 | * MYB_26560356_Chip-Seq_TH1_Human | 0.97911674 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97816438 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97146557 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96852664 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96497483 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96171335 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95915136 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95724047 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94857776 |
| 102 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94645540 |
| 103 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93876015 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93776043 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92553108 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91783982 |
| 107 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91399808 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90757668 |
| 109 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89736553 |
| 110 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88047472 |
| 111 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87072454 |
| 112 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.84856619 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84850602 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83480213 |
| 115 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83420985 |
| 116 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83290003 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82891680 |
| 118 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.82459799 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81614542 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81548421 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80910347 |
| 122 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78862717 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.78736465 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78604079 |
| 125 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78540804 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77832781 |
| 127 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.77320228 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77199382 |
| 129 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.76968964 |
| 130 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.76050494 |
| 131 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74968004 |
| 132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74949097 |
| 133 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74750458 |
| 134 | AR_19668381_ChIP-Seq_PC3_Human | 0.74221280 |
| 135 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74207288 |
| 136 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74055953 |
| 137 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73971556 |
| 138 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73858757 |
| 139 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.73565438 |
| 140 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73352632 |
| 141 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72814531 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72661073 |
| 143 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72626048 |
| 144 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72609890 |
| 145 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72493629 |
| 146 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.71443359 |
| 147 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.71443359 |
| 148 | TBL1_22424771_ChIP-Seq_293T_Human | 0.70976285 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.70838373 |
| 150 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70682573 |
| 151 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.70177293 |
| 152 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.69520136 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.69269545 |
| 154 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.68114580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.82520188 |
| 2 | MP0005365_abnormal_bile_salt | 3.98398865 |
| 3 | MP0005360_urolithiasis | 3.91914425 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.70951114 |
| 5 | MP0003252_abnormal_bile_duct | 3.44565130 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.20707993 |
| 7 | MP0005670_abnormal_white_adipose | 2.93919790 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.79154475 |
| 9 | MP0000751_myopathy | 2.66020154 |
| 10 | MP0004130_abnormal_muscle_cell | 2.57089884 |
| 11 | MP0002009_preneoplasia | 2.54637625 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.51150615 |
| 13 | MP0004145_abnormal_muscle_electrophysio | 2.39692202 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.37048687 |
| 15 | MP0005083_abnormal_biliary_tract | 2.36918114 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.23627571 |
| 17 | MP0008260_abnormal_autophagy | 2.20730286 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.18912522 |
| 19 | MP0003646_muscle_fatigue | 2.16908461 |
| 20 | MP0003690_abnormal_glial_cell | 2.14553307 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.13507747 |
| 22 | MP0003195_calcinosis | 2.08056050 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.02473319 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.01630487 |
| 25 | MP0004043_abnormal_pH_regulation | 1.98889024 |
| 26 | MP0005375_adipose_tissue_phenotype | 1.95837923 |
| 27 | MP0009278_abnormal_bone_marrow | 1.93281260 |
| 28 | MP0004036_abnormal_muscle_relaxation | 1.92391200 |
| 29 | MP0000749_muscle_degeneration | 1.86311524 |
| 30 | MP0003303_peritoneal_inflammation | 1.78084702 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.77434687 |
| 32 | MP0005332_abnormal_amino_acid | 1.76672541 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.75279727 |
| 34 | MP0000747_muscle_weakness | 1.74451636 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.72227509 |
| 36 | MP0005409_darkened_coat_color | 1.67139056 |
| 37 | MP0003436_decreased_susceptibility_to | 1.64674051 |
| 38 | MP0003329_amyloid_beta_deposits | 1.63092400 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.61434455 |
| 40 | MP0002269_muscular_atrophy | 1.59850862 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.58507336 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.55829865 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.54801189 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.54406889 |
| 45 | MP0002971_abnormal_brown_adipose | 1.54117923 |
| 46 | MP0003091_abnormal_cell_migration | 1.52743585 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.50035058 |
| 48 | MP0005451_abnormal_body_composition | 1.48746398 |
| 49 | MP0005330_cardiomyopathy | 1.47424809 |
| 50 | MP0003868_abnormal_feces_composition | 1.47253871 |
| 51 | MP0000609_abnormal_liver_physiology | 1.42984684 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.42446339 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.41577608 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.40728059 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.37894815 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.37632054 |
| 57 | MP0005620_abnormal_muscle_contractility | 1.37231444 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.36739034 |
| 59 | MP0003828_pulmonary_edema | 1.35710789 |
| 60 | MP0004084_abnormal_cardiac_muscle | 1.33557104 |
| 61 | MP0004381_abnormal_hair_follicle | 1.33120211 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.31814453 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.31814453 |
| 64 | MP0003283_abnormal_digestive_organ | 1.31673212 |
| 65 | MP0002106_abnormal_muscle_physiology | 1.31608185 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.27413325 |
| 67 | MP0004859_abnormal_synaptic_plasticity | 1.26141208 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.25249909 |
| 69 | MP0001765_abnormal_ion_homeostasis | 1.25048631 |
| 70 | MP0000759_abnormal_skeletal_muscle | 1.23804659 |
| 71 | MP0001661_extended_life_span | 1.22737192 |
| 72 | MP0002166_altered_tumor_susceptibility | 1.22566923 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 1.22342334 |
| 74 | MP0009840_abnormal_foam_cell | 1.21071081 |
| 75 | MP0004947_skin_inflammation | 1.20790547 |
| 76 | MP0003045_fibrosis | 1.20304593 |
| 77 | MP0001851_eye_inflammation | 1.17265044 |
| 78 | MP0002928_abnormal_bile_duct | 1.17082616 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.14357025 |
| 80 | MP0005369_muscle_phenotype | 1.14203419 |
| 81 | MP0001944_abnormal_pancreas_morphology | 1.10474465 |
| 82 | MP0004858_abnormal_nervous_system | 1.10218430 |
| 83 | MP0010630_abnormal_cardiac_muscle | 1.09529250 |
| 84 | MP0005334_abnormal_fat_pad | 1.05823599 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 1.03989093 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 1.02743069 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 1.01878229 |
| 88 | MP0008569_lethality_at_weaning | 1.01103521 |
| 89 | MP0005464_abnormal_platelet_physiology | 1.00837371 |
| 90 | MP0000604_amyloidosis | 1.00198500 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.99883342 |
| 92 | MP0009115_abnormal_fat_cell | 0.99271882 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.97172236 |
| 94 | MP0000462_abnormal_digestive_system | 0.97026869 |
| 95 | MP0005647_abnormal_sex_gland | 0.95734372 |
| 96 | MP0001849_ear_inflammation | 0.95602505 |
| 97 | MP0003279_aneurysm | 0.95300148 |
| 98 | MP0002108_abnormal_muscle_morphology | 0.95119944 |
| 99 | MP0000383_abnormal_hair_follicle | 0.93434373 |
| 100 | MP0000703_abnormal_thymus_morphology | 0.93227275 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.92981043 |
| 102 | MP0004510_myositis | 0.92627979 |
| 103 | MP0002132_abnormal_respiratory_system | 0.92169358 |
| 104 | MP0000685_abnormal_immune_system | 0.91236345 |
| 105 | MP0002168_other_aberrant_phenotype | 0.89756897 |
| 106 | MP0002398_abnormal_bone_marrow | 0.89476744 |
| 107 | MP0010678_abnormal_skin_adnexa | 0.89382975 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.89231634 |
| 109 | MP0004233_abnormal_muscle_weight | 0.87800639 |
| 110 | MP0001915_intracranial_hemorrhage | 0.87406882 |
| 111 | MP0001270_distended_abdomen | 0.86904868 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86305985 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.85777488 |
| 114 | MP0002933_joint_inflammation | 0.83808737 |
| 115 | MP0000920_abnormal_myelination | 0.83247292 |
| 116 | MP0002419_abnormal_innate_immunity | 0.83232526 |
| 117 | MP0006138_congestive_heart_failure | 0.82259256 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.82213192 |
| 119 | MP0002972_abnormal_cardiac_muscle | 0.82170974 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.81456927 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.81252068 |
| 122 | MP0000579_abnormal_nail_morphology | 0.81129454 |
| 123 | MP0006054_spinal_hemorrhage | 0.80656764 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80538954 |
| 125 | MP0001873_stomach_inflammation | 0.79329153 |
| 126 | MP0003959_abnormal_lean_body | 0.79055057 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.78952501 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.78317149 |
| 129 | MP0003950_abnormal_plasma_membrane | 0.77052156 |
| 130 | MP0005621_abnormal_cell_physiology | 0.76773813 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.76592912 |
| 132 | MP0001544_abnormal_cardiovascular_syste | 0.76235854 |
| 133 | MP0005385_cardiovascular_system_phenoty | 0.76235854 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.72971364 |
| 135 | MP0004085_abnormal_heartbeat | 0.72555987 |
| 136 | MP0002405_respiratory_system_inflammati | 0.72317095 |
| 137 | MP0001835_abnormal_antigen_presentation | 0.72060643 |
| 138 | MP0009672_abnormal_birth_weight | 0.71911805 |
| 139 | MP0005025_abnormal_response_to | 0.71111229 |
| 140 | MP0002722_abnormal_immune_system | 0.70515971 |
| 141 | MP0002970_abnormal_white_adipose | 0.70230292 |
| 142 | MP0004484_altered_response_of | 0.69945607 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.69811539 |
| 144 | MP0003953_abnormal_hormone_level | 0.69119997 |
| 145 | MP0005636_abnormal_mineral_homeostasis | 0.68871906 |
| 146 | MP0000733_abnormal_muscle_development | 0.68427541 |
| 147 | MP0003011_delayed_dark_adaptation | 0.68252677 |
| 148 | MP0001756_abnormal_urination | 0.68180949 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.67218441 |
| 150 | MP0005535_abnormal_body_temperature | 0.65517156 |
| 151 | MP0001958_emphysema | 0.63925570 |
| 152 | MP0000750_abnormal_muscle_regeneration | 0.63754562 |
| 153 | MP0009642_abnormal_blood_homeostasis | 0.63418376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.77963588 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.38814755 |
| 3 | Ketosis (HP:0001946) | 4.26319998 |
| 4 | Ketoacidosis (HP:0001993) | 4.19053318 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.15471827 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.92375888 |
| 7 | Myoglobinuria (HP:0002913) | 3.86779914 |
| 8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.79743040 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.73364601 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48382820 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.30026137 |
| 12 | Difficulty running (HP:0009046) | 3.26001777 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 3.23748180 |
| 14 | Xanthomatosis (HP:0000991) | 3.21585957 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.18656602 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.05026846 |
| 17 | Hyperkalemia (HP:0002153) | 3.02754419 |
| 18 | Hyperglycinuria (HP:0003108) | 3.01961935 |
| 19 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.01080344 |
| 20 | Hyperammonemia (HP:0001987) | 2.99118405 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 2.97358107 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.96935044 |
| 23 | Renal cortical cysts (HP:0000803) | 2.96876651 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95263185 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 2.95263185 |
| 26 | Broad metatarsal (HP:0001783) | 2.92951217 |
| 27 | Obstructive sleep apnea (HP:0002870) | 2.91969957 |
| 28 | Muscle fiber splitting (HP:0003555) | 2.90007549 |
| 29 | Myopathic facies (HP:0002058) | 2.84349350 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.78936357 |
| 31 | Gout (HP:0001997) | 2.78521616 |
| 32 | Hyperglycemia (HP:0003074) | 2.78509831 |
| 33 | Prolonged partial thromboplastin time (HP:0003645) | 2.76556465 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.66673797 |
| 35 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.65892571 |
| 36 | Sudden death (HP:0001699) | 2.65141941 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.64941242 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.59787251 |
| 39 | Colitis (HP:0002583) | 2.59570282 |
| 40 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.59207003 |
| 41 | Complement deficiency (HP:0004431) | 2.56398186 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.55955161 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.54553831 |
| 44 | Eczematoid dermatitis (HP:0000976) | 2.53949294 |
| 45 | Muscle fiber inclusion bodies (HP:0100299) | 2.52884345 |
| 46 | Bundle branch block (HP:0011710) | 2.52018769 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.51680552 |
| 48 | Subaortic stenosis (HP:0001682) | 2.51680552 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48116501 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.48116501 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.45906302 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.45531409 |
| 53 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.43186916 |
| 54 | Rhabdomyolysis (HP:0003201) | 2.41533387 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.40059693 |
| 56 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37607068 |
| 57 | Dysmetric saccades (HP:0000641) | 2.37228479 |
| 58 | Polycythemia (HP:0001901) | 2.37033439 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.36943938 |
| 60 | Symptomatic seizures (HP:0011145) | 2.36555954 |
| 61 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.34734885 |
| 62 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.34734885 |
| 63 | Hypoplastic ischia (HP:0003175) | 2.33275979 |
| 64 | Reticulocytosis (HP:0001923) | 2.33207284 |
| 65 | Late onset (HP:0003584) | 2.32162169 |
| 66 | Epidermoid cyst (HP:0200040) | 2.29961383 |
| 67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.27362988 |
| 68 | Hyperglycinemia (HP:0002154) | 2.25736073 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.24584143 |
| 70 | Abnormality of the calf musculature (HP:0001430) | 2.23885421 |
| 71 | Increased connective tissue (HP:0009025) | 2.23852863 |
| 72 | Abnormality of complement system (HP:0005339) | 2.23576518 |
| 73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.19722554 |
| 74 | Hyperuricemia (HP:0002149) | 2.19094196 |
| 75 | Increased purine levels (HP:0004368) | 2.19094196 |
| 76 | Abnormality of the ischium (HP:0003174) | 2.18781268 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.18062190 |
| 78 | Round ear (HP:0100830) | 2.16352685 |
| 79 | Large for gestational age (HP:0001520) | 2.14427496 |
| 80 | Joint hemorrhage (HP:0005261) | 2.14093035 |
| 81 | Right ventricular cardiomyopathy (HP:0011663) | 2.11251238 |
| 82 | Metabolic acidosis (HP:0001942) | 2.09602464 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.07404138 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07307646 |
| 85 | Cellulitis (HP:0100658) | 2.07189176 |
| 86 | Abnormality of potassium homeostasis (HP:0011042) | 2.06224965 |
| 87 | Bowel incontinence (HP:0002607) | 2.05809737 |
| 88 | Elfin facies (HP:0004428) | 2.05764176 |
| 89 | Fatigue (HP:0012378) | 2.05084628 |
| 90 | Enlarged kidneys (HP:0000105) | 2.03472107 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.03053761 |
| 92 | Hypolipoproteinemia (HP:0010981) | 2.02830932 |
| 93 | Abnormality of methionine metabolism (HP:0010901) | 2.00428734 |
| 94 | Heart block (HP:0012722) | 1.99773652 |
| 95 | Increased IgE level (HP:0003212) | 1.99731079 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 1.96507023 |
| 97 | Germ cell neoplasia (HP:0100728) | 1.96291829 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96265874 |
| 99 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96245410 |
| 100 | Ankle clonus (HP:0011448) | 1.96096010 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 1.96063299 |
| 102 | Prolonged QT interval (HP:0001657) | 1.95571274 |
| 103 | Aneurysm (HP:0002617) | 1.95305833 |
| 104 | Muscle stiffness (HP:0003552) | 1.93135503 |
| 105 | Papilledema (HP:0001085) | 1.92946874 |
| 106 | Metaphyseal cupping (HP:0003021) | 1.92421892 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 1.92419684 |
| 108 | Spontaneous hematomas (HP:0007420) | 1.92267920 |
| 109 | Dilated cardiomyopathy (HP:0001644) | 1.92182677 |
| 110 | Abnormality of the fingertips (HP:0001211) | 1.92017625 |
| 111 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91841115 |
| 112 | Cholelithiasis (HP:0001081) | 1.91535084 |
| 113 | Hyperbilirubinemia (HP:0002904) | 1.91360415 |
| 114 | Hyperacusis (HP:0010780) | 1.91304093 |
| 115 | Abnormality of the foot musculature (HP:0001436) | 1.89492558 |
| 116 | Renovascular hypertension (HP:0100817) | 1.88858455 |
| 117 | Insulin resistance (HP:0000855) | 1.88355466 |
| 118 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.87963716 |
| 119 | Interstitial pulmonary disease (HP:0006530) | 1.85566174 |
| 120 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84670039 |
| 121 | Neck muscle weakness (HP:0000467) | 1.83866407 |
| 122 | Skin nodule (HP:0200036) | 1.83774471 |
| 123 | Turricephaly (HP:0000262) | 1.82895531 |
| 124 | Hypokalemia (HP:0002900) | 1.82594912 |
| 125 | Distal arthrogryposis (HP:0005684) | 1.82565677 |
| 126 | Nemaline bodies (HP:0003798) | 1.82393542 |
| 127 | Flat acetabular roof (HP:0003180) | 1.81903568 |
| 128 | Cerebral inclusion bodies (HP:0100314) | 1.81424152 |
| 129 | Abnormal large intestine physiology (HP:0012700) | 1.80378557 |
| 130 | EMG: myopathic abnormalities (HP:0003458) | 1.79731313 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.78833794 |
| 132 | Back pain (HP:0003418) | 1.78356967 |
| 133 | Ankyloglossia (HP:0010296) | 1.78007288 |
| 134 | Proximal tubulopathy (HP:0000114) | 1.76776686 |
| 135 | Slow saccadic eye movements (HP:0000514) | 1.76375660 |
| 136 | Atrial fibrillation (HP:0005110) | 1.75772600 |
| 137 | Atrioventricular block (HP:0001678) | 1.75413755 |
| 138 | Protrusio acetabuli (HP:0003179) | 1.74374767 |
| 139 | Seborrheic dermatitis (HP:0001051) | 1.73995052 |
| 140 | Abnormality of the calcaneus (HP:0008364) | 1.73744862 |
| 141 | Neonatal hypoglycemia (HP:0001998) | 1.73723373 |
| 142 | * EMG: neuropathic changes (HP:0003445) | 1.72610383 |
| 143 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.72409265 |
| 144 | Lower limb amyotrophy (HP:0007210) | 1.72268026 |
| 145 | Vertebral compression fractures (HP:0002953) | 1.71939396 |
| 146 | Broad face (HP:0000283) | 1.69205881 |
| 147 | Inflammation of the large intestine (HP:0002037) | 1.67973707 |
| 148 | Vertebral arch anomaly (HP:0008438) | 1.67791042 |
| 149 | Systemic lupus erythematosus (HP:0002725) | 1.66610555 |
| 150 | Neurofibrillary tangles (HP:0002185) | 1.64728999 |
| 151 | Abnormal gallbladder physiology (HP:0012438) | 1.63824038 |
| 152 | Cholecystitis (HP:0001082) | 1.63824038 |
| 153 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61990663 |
| 154 | Abnormality of the thoracic spine (HP:0100711) | 1.60898544 |
| 155 | Arterial tortuosity (HP:0005116) | 1.58570926 |
| 156 | Prolonged bleeding time (HP:0003010) | 1.57904008 |
| 157 | Gingivitis (HP:0000230) | 1.57874647 |
| 158 | Macroorchidism (HP:0000053) | 1.57577356 |
| 159 | Stridor (HP:0010307) | 1.57038827 |
| 160 | Glomerulonephritis (HP:0000099) | 1.56717078 |
| 161 | Visceral angiomatosis (HP:0100761) | 1.55750376 |
| 162 | Aortic aneurysm (HP:0004942) | 1.55040078 |
| 163 | Heterotopia (HP:0002282) | 1.54858934 |
| 164 | Peripheral hypomyelination (HP:0007182) | 1.54848831 |
| 165 | Gingival bleeding (HP:0000225) | 1.54385378 |
| 166 | Poikilocytosis (HP:0004447) | 1.53702814 |
| 167 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.53292163 |
| 168 | Frequent falls (HP:0002359) | 1.53273654 |
| 169 | Epistaxis (HP:0000421) | 1.51884958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.48291793 |
| 2 | SIK1 | 3.24602129 |
| 3 | INSRR | 3.22606333 |
| 4 | TRIB3 | 3.20113499 |
| 5 | EEF2K | 2.80742556 |
| 6 | TTN | 2.61356036 |
| 7 | BCKDK | 2.52951136 |
| 8 | PKN2 | 2.42041878 |
| 9 | TAOK3 | 2.36277589 |
| 10 | LATS1 | 2.30849348 |
| 11 | EPHB1 | 2.15375588 |
| 12 | CAMK1D | 2.14335227 |
| 13 | OBSCN | 2.04397833 |
| 14 | CAMK1G | 2.01264112 |
| 15 | FLT3 | 1.83824326 |
| 16 | FGFR4 | 1.81542748 |
| 17 | PHKG1 | 1.78975142 |
| 18 | PHKG2 | 1.78975142 |
| 19 | PTK6 | 1.68968117 |
| 20 | MAP3K7 | 1.64199262 |
| 21 | RIPK1 | 1.63883745 |
| 22 | RIPK4 | 1.63553488 |
| 23 | PIK3CG | 1.57595933 |
| 24 | DMPK | 1.56575032 |
| 25 | KSR2 | 1.45816598 |
| 26 | SMG1 | 1.45174090 |
| 27 | TYK2 | 1.43364608 |
| 28 | LMTK2 | 1.39470689 |
| 29 | MAPK15 | 1.34778169 |
| 30 | PRKAA2 | 1.33690434 |
| 31 | ERN1 | 1.32909791 |
| 32 | WNK4 | 1.31987868 |
| 33 | HIPK2 | 1.31644458 |
| 34 | MAP4K1 | 1.30019503 |
| 35 | ZAP70 | 1.29329803 |
| 36 | TIE1 | 1.28457836 |
| 37 | PDGFRA | 1.27986131 |
| 38 | MAP3K10 | 1.22273997 |
| 39 | PRKD2 | 1.14818579 |
| 40 | PRKD3 | 1.13907086 |
| 41 | PINK1 | 1.12480253 |
| 42 | FGFR2 | 1.10976800 |
| 43 | MAP2K3 | 1.09717611 |
| 44 | MAPK11 | 1.09381778 |
| 45 | WNK1 | 1.08979396 |
| 46 | EPHA3 | 1.05514165 |
| 47 | PRKCH | 1.05208973 |
| 48 | MAP3K6 | 1.04155145 |
| 49 | RET | 1.01133434 |
| 50 | PRKAA1 | 0.98945384 |
| 51 | TNK2 | 0.98472960 |
| 52 | FES | 0.97627140 |
| 53 | TGFBR2 | 0.95537395 |
| 54 | PRKD1 | 0.95529717 |
| 55 | SGK3 | 0.91434538 |
| 56 | MAPK7 | 0.90983408 |
| 57 | MARK2 | 0.85100869 |
| 58 | MAP3K14 | 0.84782164 |
| 59 | ICK | 0.80982178 |
| 60 | JAK1 | 0.79722595 |
| 61 | BLK | 0.79640313 |
| 62 | CDC42BPA | 0.77895321 |
| 63 | BTK | 0.77668770 |
| 64 | UHMK1 | 0.75304305 |
| 65 | PASK | 0.74696577 |
| 66 | CAMKK1 | 0.74386024 |
| 67 | MAP2K4 | 0.72853190 |
| 68 | STK39 | 0.71783712 |
| 69 | MAPKAPK3 | 0.71268151 |
| 70 | NLK | 0.70749841 |
| 71 | BRD4 | 0.70441156 |
| 72 | MAP2K2 | 0.70343955 |
| 73 | CDK6 | 0.70252520 |
| 74 | HCK | 0.69942396 |
| 75 | MTOR | 0.69851258 |
| 76 | MAP3K13 | 0.69352501 |
| 77 | NTRK1 | 0.68631077 |
| 78 | MAPK12 | 0.68509131 |
| 79 | TYRO3 | 0.68026810 |
| 80 | AKT3 | 0.67618125 |
| 81 | PIK3CA | 0.67152783 |
| 82 | SIK2 | 0.65217184 |
| 83 | TBK1 | 0.65040082 |
| 84 | MAPK10 | 0.65011419 |
| 85 | SGK2 | 0.64764329 |
| 86 | GRK1 | 0.64606542 |
| 87 | SGK494 | 0.64537451 |
| 88 | SGK223 | 0.64537451 |
| 89 | MAP3K2 | 0.63611750 |
| 90 | JAK2 | 0.62378022 |
| 91 | PTK2 | 0.61811138 |
| 92 | BMX | 0.60774346 |
| 93 | STK3 | 0.59363597 |
| 94 | GRK6 | 0.59038388 |
| 95 | RPS6KC1 | 0.58688989 |
| 96 | RPS6KL1 | 0.58688989 |
| 97 | NEK6 | 0.57792351 |
| 98 | NTRK3 | 0.57025399 |
| 99 | PAK3 | 0.56830331 |
| 100 | PDGFRB | 0.56244375 |
| 101 | TRPM7 | 0.55628266 |
| 102 | PAK6 | 0.54706443 |
| 103 | MAPKAPK5 | 0.54644997 |
| 104 | NEK9 | 0.54496283 |
| 105 | CDK9 | 0.54052823 |
| 106 | PKN1 | 0.53549361 |
| 107 | CDK4 | 0.52734758 |
| 108 | CAMK4 | 0.52349075 |
| 109 | STK38 | 0.52154137 |
| 110 | KIT | 0.52069436 |
| 111 | PDPK1 | 0.51880856 |
| 112 | SYK | 0.51696304 |
| 113 | MUSK | 0.50651836 |
| 114 | OXSR1 | 0.49906992 |
| 115 | SIK3 | 0.49789204 |
| 116 | MAP3K1 | 0.48988183 |
| 117 | FGFR3 | 0.46264245 |
| 118 | PDK1 | 0.45700206 |
| 119 | DYRK1B | 0.45628498 |
| 120 | MAPK3 | 0.44833789 |
| 121 | CSK | 0.43970639 |
| 122 | LRRK2 | 0.43074021 |
| 123 | SGK1 | 0.42247653 |
| 124 | MET | 0.41935144 |
| 125 | DAPK2 | 0.41802302 |
| 126 | ERBB2 | 0.39233924 |
| 127 | PAK2 | 0.39058418 |
| 128 | IRAK2 | 0.38861631 |
| 129 | CDK12 | 0.37059878 |
| 130 | ERBB4 | 0.36919018 |
| 131 | RPS6KA2 | 0.36740660 |
| 132 | ITK | 0.35044627 |
| 133 | NUAK1 | 0.34444438 |
| 134 | JAK3 | 0.34215150 |
| 135 | GSK3A | 0.33776490 |
| 136 | ROCK1 | 0.31827140 |
| 137 | TAOK1 | 0.31826449 |
| 138 | DYRK3 | 0.31399626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18488133 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.02621613 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.00236135 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.82042425 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.69067837 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49775095 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.39208277 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.33049953 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32149458 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.13721843 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 2.13092368 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01236136 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96393320 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96287854 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.84117588 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80990025 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74186981 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.72739099 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.67377979 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.60887487 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58836768 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58573771 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55790090 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53666441 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52634902 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51321973 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51111363 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.41585958 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40647981 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.40598680 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39292655 |
| 32 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.38408934 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37812742 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.36411762 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34740905 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32747344 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31556575 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26716746 |
| 39 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.25969056 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.24923496 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.23707791 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23097067 |
| 43 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.22239226 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20513835 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19676705 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17704552 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.15847706 |
| 48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.15128722 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11925421 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11531058 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10416170 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09147436 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06426271 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04462187 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03685587 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02940983 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02242182 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 1.00286761 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98747923 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96650492 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95979660 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95979612 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95585765 |
| 64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.93921755 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93876959 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93589473 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92917490 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92571065 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92437503 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92162671 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90660430 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90023629 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88651666 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88040361 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87430779 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86885576 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85049188 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.84387494 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.83978874 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.83206658 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80376412 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80162215 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75923136 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74708184 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74528056 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73778709 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73191032 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73172175 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.73144096 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.72075313 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72029401 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70458738 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69828132 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.68830098 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68463905 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68445804 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68125002 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65921947 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65869437 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64387864 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63910003 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61925845 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60208574 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59807845 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59123869 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58556667 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.58506877 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57746898 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.57275817 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.56915408 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55735794 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55573446 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54681637 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54516905 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53699564 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52972691 |
| 117 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52458503 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52032524 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52015226 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50272998 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50242782 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.48610494 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48085030 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47934627 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47010958 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45276962 |
| 127 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45261288 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43618844 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40976459 |
| 130 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38341079 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37711322 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35123575 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | 0.35005631 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34254730 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34097972 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32566972 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32153047 |
| 138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32118638 |
| 139 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32110764 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31821254 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.31487649 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28762035 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28446856 |
| 144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26967789 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26624247 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25916163 |
| 147 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25639652 |
| 148 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25348481 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22558270 |
| 150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22444614 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22389803 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21198650 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18721974 |

